BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16310537)

  • 1. Total lymphocyte counts and ART in resource-limited settings.
    Moore D; Montaner J
    Lancet; 2005 Nov; 366(9500):1831-2. PubMed ID: 16310537
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of HIV infection: are we failing children?
    Augusto GF
    Lancet Infect Dis; 2012 Sep; 12(9):664-53. PubMed ID: 23082327
    [No Abstract]   [Full Text] [Related]  

  • 4. Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count.
    De Beaudrap P; Boullé C; Lewden C; Gabillard D; Nacro B; Diagbouga S; Fassinou P; Hien H; Laurent C; Msellati P;
    Pediatr Infect Dis J; 2013 Apr; 32(4):354-60. PubMed ID: 23099424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3.7 HIV and AIDS.
    Saloojee H; Cooper P
    World Rev Nutr Diet; 2015; 113():173-7. PubMed ID: 25906879
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune reconstitution inflammatory syndrome.
    Surjushe AU; Jindal SR; Kamath RR; Saple DG
    Indian J Dermatol Venereol Leprol; 2006; 72(6):410-4. PubMed ID: 17179614
    [No Abstract]   [Full Text] [Related]  

  • 7. Change in absolute CD4 count with antiretroviral treatment in resource limited setting: a retrospective cohort study in children in Ethiopia.
    Berhan Y
    Ethiop Med J; 2011 Oct; 49(4):289-98. PubMed ID: 23409394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings.
    Schneider K; Puthanakit T; Kerr S; Law MG; Cooper DA; Donovan B; Phanuphak N; Sirisanthana V; Ananworanich J; Ohata J; Wilson DP
    AIDS; 2011 Jun; 25(9):1143-51. PubMed ID: 21505319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival time of AIDS patients in Bamrasnaradura Institute.
    Chaovavanich A; Chottanapund S; Ausavapipit J; Adulyawat N; Ubonsai W
    J Med Assoc Thai; 2006 Nov; 89(11):1859-63. PubMed ID: 17205866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 seroreversion following antiretroviral therapy in an HIV-infected child initially presenting with acquired immunodeficiency syndrome.
    Neubert J; Laws HJ; Adams O; Münk C; Krämer M; Niehues T; Korn K; Fleckenstein B; Petri E; Borkhardt A
    AIDS; 2010 Jan; 24(2):327-8. PubMed ID: 20029271
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral therapy in resource-poor settings: scaling up inequalities?
    Egger M; Boulle A; Schechter M; Miotti P
    Int J Epidemiol; 2005 Jun; 34(3):509-12. PubMed ID: 15941732
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiretroviral treatment adherence and its association with TCD4+ lymphocyte subsets in children with HIV/AIDS].
    Balbaryski J; Simonte K; Urteneche I; Candi M; Gaddi E; Barboni G
    Medicina (B Aires); 2013; 73(4):324-30. PubMed ID: 23924530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of antiretroviral therapy on AIDS and survival.
    Lundgren JD; Mocroft A
    J HIV Ther; 2006 Jun; 11(2):36-8. PubMed ID: 16981594
    [No Abstract]   [Full Text] [Related]  

  • 14. [Retroviruses and opportunistic diseases: the catch of intermittent treatments?].
    Nau JY
    Rev Med Suisse; 2006 Feb; 2(54):553. PubMed ID: 16562541
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in antiretroviral therapy.
    Taylor B; Olender S; Wilkin TJ; Hammer SM
    Top Antivir Med; 2011; 19(2):69-97. PubMed ID: 21868824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Art rollout--the clock ticks ever louder.
    Bateman C
    S Afr Med J; 2005 Jul; 95(7):459-60, 462, 464. PubMed ID: 16156436
    [No Abstract]   [Full Text] [Related]  

  • 17. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.
    Bishai D; Colchero A; Durack DT
    AIDS; 2007 Jun; 21(10):1333-40. PubMed ID: 17545710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational research: application to HIV/AIDS.
    Valenti WM
    AIDS Read; 2007 Jun; 17(6):319-21. PubMed ID: 17632939
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for mortality in a south Indian population on generic antiretroviral therapy.
    Rupali P; Mannam S; Bella A; John L; Rajkumar S; Clarence P; Pulimood SA; Samuel P; Karthik R; Abraham OC; Mathai D
    J Assoc Physicians India; 2012 Dec; 60():11-4. PubMed ID: 23781664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.